Tillar Wenstrup Advisors, LLC Gsk PLC Transaction History

Tillar Wenstrup Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$37.8 - $42.69 $1.99 Million - $2.25 Million	-52,626 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$39.75 - $42.69 $37,444 - $40,213	-942 Reduced 1.76%	52,626 $2.11 Million
Q2 2018 Aug 13, 2018	SELL	$39.61 - $42.76 $74,070 - $79,961	-1,870 Reduced 3.37%	53,568 $2.16 Million
Q1 2018 May 22, 2018	BUY	$36.18 - $40.15 $2.01 Million - $2.23 Million	55,438 New	55,438 $2.17 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Tillar Wenstrup Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tillar Wenstrup Advisors, LLC with notifications on news.